CBD 2021: Guide to Medicinal Cannabis (CHES)

Suggested Performance Indicators: 1.2.1, 1.3.3, 2.2.4, 3.2.2, 4.1.1, 4.1.2, 4.2.6, 4.2.7, 6.1.2, 6.1.9, 6.2.5, 8.1.1, 8.1.2, 8.1.5, 8.2.3, 8.3.1, 8.3.7, 10.1.1, 10.2.4, 10.2.11, 10.4.2, 10.4.4

740 Online/Web-based Course 

CHES Competencies:

1.1.4 Apply theories and/or models to assessment process 

1.1.5 Apply ethical principals to the assessment process 

1.2.3 Review related literature 

1.4.3 Identify the impact of emerging, social, economic, and other trends on health

3.1.6 Comply with legal standards that apply to implementation

MCHES Competencies:

1.1.4 Apply theories and/or models to assessment process

Upon successful completion, the users will be able to:

1. Identify the neurochemical that CBD makes more available thus becoming effective treatment.

2. Name the body organ with the largest number of CB1 receptors and which system has CB2 receptors.

3. Describe how the endocannabinoid system works in the human body.

4. Discuss one health function of each: limonene, linalool, and phellandrene.

5. Identify the delivery method for CBD with the highest bioavailability.

6. Compare and contrast characteristics and uses for: Sativex, Indica, AC/DC, and Dronabinol.

7. Discuss dosing ranges for micro and macro dosing of CBD, and the safest way to find the correct individual dose.

8. List three possible side effects to watch for especially when taking a product with THC.

9. Discuss benefits or risks for people taking CBD and the following diagnoses: insulin resistance, obesity, ADD/ADHD, opioid overdose rate, Alzheimer’s disease, arthritis, skin cancer, multiple sclerosis, and seizures.

10. Describe under which circumstances or for which diagnoses, standard dose 20:1 CBD:THC ratio is used.

11. Identify three times in a woman’s life when treatment with CBD is especially effective.

12. Identify the cannabis strain used to treat pediatric seizure disorders.

13. Describe two current legal issues associated with CBD production and use.